aspirin has been researched along with Hyperlipoproteinemias in 4 studies
Aspirin: The prototypical analgesic used in the treatment of mild to moderate pain. It has anti-inflammatory and antipyretic properties and acts as an inhibitor of cyclooxygenase which results in the inhibition of the biosynthesis of prostaglandins. Aspirin also inhibits platelet aggregation and is used in the prevention of arterial and venous thrombosis. (From Martindale, The Extra Pharmacopoeia, 30th ed, p5)
acetylsalicylate : A benzoate that is the conjugate base of acetylsalicylic acid, arising from deprotonation of the carboxy group.
acetylsalicylic acid : A member of the class of benzoic acids that is salicylic acid in which the hydrogen that is attached to the phenolic hydroxy group has been replaced by an acetoxy group. A non-steroidal anti-inflammatory drug with cyclooxygenase inhibitor activity.
Hyperlipoproteinemias: Conditions with abnormally elevated levels of LIPOPROTEINS in the blood. They may be inherited, acquired, primary, or secondary. Hyperlipoproteinemias are classified according to the pattern of lipoproteins on electrophoresis or ultracentrifugation.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Ciprofibrate is an effective hypolipidemic agent, also lowering the level of fibrinogen." | 5.30 | [The effect of monotherapy with ciprofibrate and in combination with acetylsalicylic acid on the spectrum of lipids, thromboxane and fibrinogen in patients with atherosclerosis and hyperlipoproteinemia]. ( Cibulova, L; Fedelesova, V; Gajdos, M; Huttova, D; Krivosikova, Z; Mongiellova, V; Polak, F, 1999) |
| " Long term use of these drugs may prevent deterioration in those patients with progressive disease, and controlled trials on this aspect of treatment are now required." | 2.36 | Can drugs help patients with lower limb ischaemia? ( Bell, PR; Boobis, LH, 1982) |
| "Ciprofibrate is an effective hypolipidemic agent, also lowering the level of fibrinogen." | 1.30 | [The effect of monotherapy with ciprofibrate and in combination with acetylsalicylic acid on the spectrum of lipids, thromboxane and fibrinogen in patients with atherosclerosis and hyperlipoproteinemia]. ( Cibulova, L; Fedelesova, V; Gajdos, M; Huttova, D; Krivosikova, Z; Mongiellova, V; Polak, F, 1999) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (25.00) | 18.7374 |
| 1990's | 2 (50.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (25.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Zsíros, N | 1 |
| Paragh, G | 1 |
| Harangi, M | 1 |
| Boobis, LH | 1 |
| Bell, PR | 1 |
| Jastrzebska, M | 1 |
| Torbus-Lisiecka, B | 1 |
| Pieczul-Mróz, J | 1 |
| Chełstowski, K | 1 |
| Gajdos, M | 1 |
| Fedelesova, V | 1 |
| Mongiellova, V | 1 |
| Cibulova, L | 1 |
| Huttova, D | 1 |
| Polak, F | 1 |
| Krivosikova, Z | 1 |
2 reviews available for aspirin and Hyperlipoproteinemias
| Article | Year |
|---|---|
[Clinical significance of and treatment options for increased lipoprotein(a)].
Topics: Aspirin; Biomarkers; Blood Component Removal; Cardiovascular Diseases; Carrier Proteins; Cholesterol | 2014 |
Can drugs help patients with lower limb ischaemia?
Topics: Aged; Arteriosclerosis; Aspirin; Cholesterol; Collateral Circulation; Female; Hemodynamics; Humans; | 1982 |
1 trial available for aspirin and Hyperlipoproteinemias
| Article | Year |
|---|---|
[Evaluation of platelet function and tissue plasminogen activator activity in ischemic heart disease depending on concurrence with hyperlipoproteinemia and aspirin therapy].
Topics: Adult; Anti-Inflammatory Agents, Non-Steroidal; Aspirin; Fibrinolysis; Humans; Hyperlipoproteinemias | 1997 |
1 other study available for aspirin and Hyperlipoproteinemias
| Article | Year |
|---|---|
[The effect of monotherapy with ciprofibrate and in combination with acetylsalicylic acid on the spectrum of lipids, thromboxane and fibrinogen in patients with atherosclerosis and hyperlipoproteinemia].
Topics: Aged; Arteriosclerosis; Aspirin; Clofibric Acid; Drug Therapy, Combination; Female; Fibric Acids; Fi | 1999 |